Burfiralimab Antibody
Burfiralimab (hzVSF-v13) is an anti-vascular stromal fibroblast (VSF) IgG4 monoclonal antibody with demonstrated anti-HBV activity. It serves as a research tool for investigating rheumatoid arthritis and related autoimmune pathologies, with utility in both in vitro cellular assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
HzVSF-v13, HBV
Target
Interleukin, SARS-CoV, HBV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Infectious Disease & Virology
Concentration
9.82 mg/mL
Purity
90.00% (May vary between batches)
Molecular Weight
144.6 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
